Replies to post #43141 on Genta, Inc (fka GNTAQ)

[STLCardinalsFan]

Confirmation bias. You need to look up the meaning of that term.

This company, if past history is the norm, is preparing for another round of dilution. This stock will only go down in price as they have no meaningful revenue stream aside from the aforementioned R/S.
Again, as I've been saying for over a year, there is no partnership and there will be no FDA approval for at least 1-2 years. There is no positive momentum for this company in light of the pending R/S vote. I thought Genasense had a solid chance of approval given the data we all had on hand. As the situation changed, my educated opinion on Genta has evolved.

DUMP.